|
시장보고서
상품코드
2054426
바이오의약품 CMO 및 CRO 시장 : 유래별, 서비스별, 제품별, 지역별Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
바이오의약품 CMO 및 CRO 시장은 2026년에 430억 8,000만 달러로 추계되고 있으며, 2033년까지 652억 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 6.1%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모 : 2026년 | 430억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR : 2026-2033년 | 6.10% | 시장 규모 예측 : 2033년 | 652억 달러 |
바이오의약품 CMO(수탁 제조 기관)란, 바이오의약품 분야의 타 기업에 의약품 제조부터 포장까지의 서비스를 제공하는 계약 기반의 기업을 말합니다. 한편, CRO(위탁 연구 기관)란 바이오의약품 기업을 대상으로 계약을 통해 외부 위탁되는 연구 서비스 형태로 지원을 제공하는 기업입니다.
시장 역학
만성 질환의 부담 증가, 신약 개발의 활성화, 바이오의약품 및 바이오시밀러에 대한 수요 증가, 아웃소싱 확대 추세, 연구개발 투자 증가, 그리고 바이오의약품 업계의 급속한 성장이 세계 바이오의약품 CMO 및 CRO 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다.
예를 들어, 2023년 2월, Lunaphore사와 Sirona Dx사는 전략적 제휴를 발표했습니다. 이를 통해 Sirona Dx는 Lunaphore의 주력 제품인 COMET 공간생물학 플랫폼을 서비스 형태로 제공하는 미국 최초의 CRO(의약품 개발 수탁 기관)가 됩니다. COMET은 Sirona Dx의 연구 서비스 포트폴리오를 보완하여 다양한 분야의 연구자 및 바이오의약품 팀의 요구를 충족시킬 것입니다. COMET은 여러 분야와 연구 개발의 전 단계에 걸쳐 폭넓은 연구 용도로 활용되고 있습니다.
본 조사의 주요 특징
- 본 조사는 서로 다른 부문별 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 세계 바이오의약품 CMO 및 CRO 시장의 주요 기업 프로파일을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 세계 바이오의약품 CMO 및 CRO 시장을 다루며, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 바이오의약품 CMO 및 CRO 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 바이오의약품 CMO 및 CRO 시장 : 유래별(2021-2033년)
제5장 세계의 바이오의약품 CMO 및 CRO 시장 : 서비스별(2021-2033년)
제6장 세계의 바이오의약품 CMO 및 CRO 시장 : 제품별(2021-2033년)
제7장 세계의 바이오의약품 CMO 및 CRO 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.06.17Biopharmaceutical CMO and CRO Market is estimated to be valued at USD 43.08 Bn in 2026 and is expected to reach USD 65.20 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 43.08 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 65.20 Bn |
Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.
Market Dynamics
Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.
For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.
Market Segmentation
- Global Biopharmaceutical CMO and CRO Market, By Source (Revenue, USD Bn, 2021 - 2033)
- Mammalian
- Non-mammalian
- Global Biopharmaceutical CMO and CRO Market, By Service (Revenue, USD Bn, 2021 - 2033)
- Contract Manufacturing
- Contract Research
- Global Biopharmaceutical CMO and CRO Market, By Product (Revenue, USD Bn, 2021 - 2033)
- Biologics
- Biosimilars
- Global Biopharmaceutical CMO and CRO Market, by Source (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Service
- Market Snapshot, By Product
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing trend of outsourcing across the globe
- Stringent regulatory framework
- Rapid growth of the biopharmaceutical industry
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Biopharmaceutical CMO and CRO Market, By Source, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Non-mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Biopharmaceutical CMO and CRO Market, By Service, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Biopharmaceutical CMO and CRO Market, By Product, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Biopharmaceutical CMO and CRO Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Allphase Clinical Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AlcheraBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alcami
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akos Urgent Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Affinity Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Actimus Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ACI Clinical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accumedix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absorption Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- A10 Clinical Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Albuquerque Clinical Trials (ACT)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced Clinical Services LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ACM Global Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accelerated Enrollment Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Contract Manufacturing
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced BioScience Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced Clinical Research Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alliance for Clinical Trials in Oncology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
